Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
Patent quality is the capacity of a granted patent to meet the statutory standards of patentability most importantly, to be novel, nonobvious, and clearly and sufficiently described. Thus, a “low quality” patent is one granted for an invention that does not meet these standards. And, although it should be clear, I want to make plain that there is a definite distinction between the quality of a patent, and its value. Although there may at times be a relationship between value and quality in patenting in an ideal world, the correlation would be rather strong at other times these characteristics will be independent. A patent’s value depends on factors well beyond those of concern to the patent law—the size of the relevant market, the relationship between the patent’s scope and a marketable good or service, and many others. Some of these factors will suggest the quality of the patent, such as the nature of the advance over the prior art, but others have little or nothing to do with patent quality as defined above. The modern patent system is entangled in policy disputes across a huge range of issues, the need to improve patent quality is essentially undisputed. Patent Quality Improvement Act of 2013 - Amends the Leahy-Smith America Invents Act to remove the eight-year sunset provision with respect to the transitional post-grant review program available to review the validity of covered business method patents, thereby making the program permanent. Mainly it is two types, a low-quality patent system is characterized by a large number of errors in the patent-granting process. Paradigmatically, thinking of these errors as being inappropriate grants that is patents granted that do not meet the standards of patentability. But errors in the patent-granting process also involve inappropriate denials, those where patentable inventions are turned away. These errors may well be as costly to society as inappropriate grants, for they may undermine the incentives for important innovations to be fully commercialized or have demoralizing effects on future research efforts. OMICS Group is an Open Access publishing journals that is responsible for the dissemination of scientific process and research articles to the global community. Its Open Access journals Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Publishing Group having over 300 leading peer reviewed Open Access journals and has organized more than 300 scientific conferences all over the world. OMICS Group has more than 1000 scientific associations and 30,000 editorial board members and 3.5 million readers to its credit. OMICS Group is a pioneer and leading Science event organizer. OMICS Group International Conferences 2014 and 2015 are instrumental in providing a momentous platform for the world renowned scientists, researchers, students, academicians, institutions, entrepreneurs and industries through International Science Conferences. The main vision and mission of OMICS Publishing Group is to provide free access to scientific literature for quick dissemination of scientific updates and it also provides source of reference and retrieval free of cost. OMICS Group organizes International conferences and Annual meetings in association with organizing committees across the world. OMICS Group conferences bring together scientists, researchers and practitioners to discuss methodological innovations, practical applications and new findings in the research areas of Science, Technology and Management. Research fellows and professors in various disciplines submit works in the form of manuscripts which undergo quality check before being approved for publication.
Pharma Patents Conferences in 2015: 1. International Patent Information Conference & Exposition 2. Global Intellectual Property Convention 3. Drug and Medical Device Litigation 4. Trade Secrets Protection & Enforcement 5. Pharma & Biotech Patent Litigation 6. Effective Trade Mark Administration 7. Best Practices For Selling Your Patents 8. Certified Patent Valuation Analyst 9. EU & US Patent Applications Lists of Societies related to pharma: 1) International Society for Pharmaceutical Engineering (ISPE) 2) American Association of Pharmaceutical Scientists (AAPS), USA 3) Austrian Association of Hospital Pharmacists (AAHP), Australia 4) Canadian Society for Pharmaceutical Sciences (CSPS), Canada 5) Chinese Pharmaceutical Association (CPA), China 6) European Federation for Pharmaceutical Sciences (EUFEPS), Europe 7) German Pharmaceutical Society (DPhG), Germany 8) Indian Pharmaceutical Association (IPA), India Major Pharma and related Companies: 1) Pfizer, USA 2) Novartis, Switzerland 3) Merck & Co., USA 4) Bayer, Germany 5) GlaxoSmithKline, U K 6) Johnson & Johnson, USA 7) Sanofi, France 8) Hoffmann–La Roche, Switzerland 9) AstraZeneca, UK 10) Abbott Laboratories, USA 11) Bristol-Myers Squibb, USA 12) Eli Lilly and Company, USA 13) Amgen, USA 14) Takeda Pharmaceutical Co., Japan
This page will be updated regularly.
This page was last updated on 09th Oct, 2014
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising